Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and ExonHit Partner to Develop Microarray for Splice Variants

NEW YORK, Nov. 15 (GenomeWeb News) - Agilent Technologies will combine its microarray platform with ExonHit's alternative RNA splicing in an attempt to develop an array technology that can monitor the expression of splice variants, the companies said today.

 

The companies presented results from an experimental splicing array of G-protein coupled receptors, which was designed by ExonHit and produced by Agilent, at the Splicing 2004 meeting, held in September in Bethesda, Md.

 

That array was bale to detect multiple isoforms of several genes, and "showed good reproducibility and specificity," the companies said in a statement today. Agilent and ExonHit "are expected to work with early test sites to generate additional experimental results," the firms said.

Financial terms of the agreement were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more